Shorts

1:16
Angela B. Smith, MD, MS, on proactively including PROs in bladder cancer trials
8 months ago
by
Angela B. Smith, MD, MS

1:01
Jesse Mills, MD, on why low T requires more than a single blood test
8 months ago
by
Jesse N. Mills, MD

0:52
Bogdana Schmidt, MD, MPH, shares why patients request nadofaragene re-induction
8 months ago
by
Bogdana Schmidt, MD, MPH

0:46
Aleece Fosnight, MSPAS, PA-C, on discussing incontinence with patients
8 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

1:50
The truth behind this urology coding myth
8 months ago
by
Jonathan Rubenstein, MD

0:40
Stacy Loeb, MD, highlights new recommendation for prostate cancer screening
8 months ago
by
Stacy Loeb, MD, MSc, PhD (Hon)(+1 more)

2:09
What’s the biggest misconception urologists have about prior authorizations?
8 months ago
by
Jonathan Rubenstein, MD

1:12
Advice for first-time urology coders from Jonathan Rubenstein, MD
9 months ago
by
Jonathan Rubenstein, MD

1:24
What’s a simple documentation habit that can prevent denials or underpayment?
9 months ago
by
Jonathan Rubenstein, MD

1:58
The 1 step urology practices can take to improve coding and reimbursement accuracy
9 months ago
by
Jonathan Rubenstein, MD

0:44
What are key things to know about coding for remote patient monitoring in urology?
9 months ago
by
Jonathan Rubenstein, MD

1:25
What coding pitfalls do you see most often with common procedures like cystoscopy or TURP?
9 months ago
by
Jonathan Rubenstein, MD

3:49
Jonathan Rubenstein, MD, clears up confusion on modifier 25
9 months ago
by
Jonathan Rubenstein, MD

1:31
What are the top CPT codes urologists should know?
9 months ago
by
Jonathan Rubenstein, MD

1:04
What’s the most common coding mistake urology practices make?
9 months ago
by
Jonathan Rubenstein, MD

1:08
Bogdana Schmidt, MD, MPH, discusses reinduction of nadofaragene in NMIBC
9 months ago
by
Bogdana Schmidt, MD, MPH

0:46
Brooke Edwards, MD, on the potential of AI in urology practices and ASCs
9 months ago
by
Brooke B. Edwards, MD

0:57
Matthew A. Love, MD, outlines the safety and efficacy of SURE for treating kidney stones
9 months ago
by
Matthew A. Love, MD

1:21
Suzanne B. Merrill, MD, FACS, on the significance of EV plus pembrolizumab in MIBC
9 months ago
by
Suzanne B. Merrill, MD, FACS

1:10
Jen-Jane Liu, MD, discusses evaluation of detalimogene voraplasmid in NMIBC
9 months ago
by
Jen-Jane Liu, MD

1:05
Angela B. Smith, MD, MS, on optimizing conversations with patients with MIBC
9 months ago
by
Angela B. Smith, MD, MS

0:50
Stephen Freedland, MD, discusses significance of EMBARK OS data
9 months ago
by
Stephen J. Freedland, MD

0:47
Monique Roobol, PhD, MSc, on what ERSPC data reveal about PSA screening
9 months ago
by
Monique Roobol, PhD, MSc

1:15
Pedro C. Barata, MD, MSc, FACP, recaps prostate cancer research at ESMO 2025
9 months ago
by
Pedro Barata, MD, MSc, FACP

0:51
Kim Chi, MD, discusses the PR.21 study of lutetium vs docetaxel in mCRPC
9 months ago
by
Kim Nguyen Chi, MD, FRCPC

2:03
Sean P. Collins, MD, PhD, discusses rectal spacers and biochemical recurrence in prostate cancer
9 months ago
by
Sean P. Collins, MD, PhD

1:26
Leila Momtazi-Mar discusses sperm retrieval in patients with Klinefelter Syndrome
9 months ago
by
Leila Momtazi-Mar

0:49
Sevann Helo, MD, offers advice on residency interviews
9 months ago
by
Sevann Helo, MD

0:50
Srikala Sridhar, MD, discusses ALPACA study in penile cancer
10 months ago
by
Srikala Sridhar, MD

0:51
Andrea Necchi, MD, discusses prognostic potential of utDNA and ctDNA in MIBC
10 months ago
by
Andrea Necchi, MD
Advertisement
Advertisement
Trending on Urology Times
1
Trial to evaluate ivonescimab plus enfortumab vedotin in urothelial carcinoma
2
FDA clears Revi Extend implant for urgency urinary incontinence
3
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
4
Alan Bryce, MD, highlights key phase 3 advances in prostate cancer
5
